Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Mayinglong Pharmaceutical Group Co Ltd
Income to Minority Interest
Mayinglong Pharmaceutical Group Co Ltd
Income to Minority Interest Peer Comparison
Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors
Company | Income to Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
|
Income to Minority Interest
-¥14m
|
CAGR 3-Years
-94%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Income to Minority Interest
-¥69.6m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-34%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Income to Minority Interest
¥36.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Income to Minority Interest
-¥28.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Income to Minority Interest
¥239.7k
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mayinglong Pharmaceutical Group Co Ltd's Income to Minority Interest?
Income to Minority Interest
-14m
CNY
Based on the financial report for Sep 30, 2023, Mayinglong Pharmaceutical Group Co Ltd's Income to Minority Interest amounts to -14m CNY.
What is Mayinglong Pharmaceutical Group Co Ltd's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 3Y
-94%
Over the last year, the Income to Minority Interest growth was -1 854%. The average annual Income to Minority Interest growth rates for Mayinglong Pharmaceutical Group Co Ltd have been -94% over the past three years .